Michael Lee Stallard

SEPTEMBER 16, 2015

Pfizer, the multinational pharmaceutical giant, has become increasingly intentional about shaping its culture. You can see evidence of Pfizer’s commitment in Ian Read’s letter to stakeholders the year after he became CEO: In 2011, we thoroughly explored what our culture is and how it needs to evolve. Pfizer people care.

Ethics 150

Ethics Pharmaceuticals Globalization Commitment 150

Strategy Driven

JULY 13, 2011

Medium-term value drivers look forward to indicate whether a company can maintain and improve its revenue growth and ROIC over the next one to five years (or longer for companies, such as pharmaceutical manufacturers, that have long product cycles). Copyright (c) 2011. As with the other measures, what is important varies by industry.

ROIC 62

ROIC Balanced Scorecard Metrics McKinsey 62

Harvard Business Review

SEPTEMBER 14, 2011

We recently visited the brand-new R&D lab of Dr Reddy's , one of India's leading pharmaceutical firms. In 2008, Dr Reddy's acquired Chirotech, Dow Chemical's R&D unit, for $32 million, and in April 2011 relocated it to a new 33,000 sq. Besides Dr Reddy's, several leading Indian firms are pioneering polycentric innovation: Tata Motors.

Globalization 9

Globalization Innovation Decentralization Chemicals 9

Harvard Business Review

DECEMBER 20, 2011

The two biggest product stories of 2011 were arguably Lipitor and the iPhone 4S. In both instances, the life-cycle management innovation involves using disintermediation to change how the customer interacts with the product. 30) of a blockbuster prescription drug. And both teach lessons that apply across many industries.

Disintermediation 15

Disintermediation Industry Pharmaceuticals Price 15

Strategy Driven

MARCH 18, 2011

The Essential Advantage : How to Win with a Capabilities-Driven Strategy. The conventional wisdom about strategy may be leading your company astray. In this unpredictable economy, traditional approaches to strategy are a luxury most companies cannot afford. SD : What is ‘capabilities-driven strategy?’. Let’s go after it.”

Resources 52

Resources Industry System Strategy 52

Harvard Business Review

DECEMBER 27, 2016

A study published in 2011 examined CEOs in the top-100 best hospitals in USNWR in three key medical specialties: cancer, digestive disorders, and cardiovascular care. But we would argue that credibility may also be signaled to important external stakeholders — future employees, patients, the pharmaceutical industry, donors, and so on.

Management 15

Management 360-Degree Feedback Mayo Training 15

Harvard Business Review

MARCH 2, 2012

As global companies focus their strategies on developed and emerging markets, they require substantial cadres of leaders capable of operating effectively anywhere in the world. In 2011, 71% of HBS's new cases were written about foreign companies. America fosters risk-taking and innovation by entrepreneurs who become global leaders.

Competitive Advantage 13

Competitive Advantage Globalization Development Intellectual Capital 13